BACLOFEN FORMULATIONS AND METHODS OF MINIMIZING PATIENT EXPOSURE TO METABOLITE VARIATIONS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240082193A1
SERIAL NO

18508830

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Baclofen formulations, including formulations that minimize variability between doses, that minimize variation in patient exposure to baclofen metabolites, and are bioequivalent in regards to baclofen versus M1 metabolite ratios of baclofen tablets.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMNEAL PHARMACEUTICALS LLCBRIDGEWATER NJ

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DEVANE, John Dublin, IE 46 371
HAMM, Sharon Odessa, US 21 17
MOHR, Wolfgang Freiburg, DE 35 315
O’MAHONY, Leonard Westmeath, IE 2 0
PENAKE, David Atlanta, US 17 40
WEINHEIMER, Manuel Neustadt an der Weinstrasse, DE 5 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation